Cytomegalovirus inhibitors of programmed cell death restrict antigen cross-presentation in the priming of antiviral CD8 T cells
PLOS Pathogens · 2024
DOI: 10.1371/journal.ppat.1012173 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Stefan Ebert und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Virology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Cross-Priming, Antigen Presentation, Cytomegalovirus Infections. Die Arbeit nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Collaborative Research Center (CRC), Clinical Research Group, Cluster of Excellence ImmunoSensation.
Abstract (Originalsprache)
CD8 T cells are the predominant effector cells of adaptive immunity in preventing cytomegalovirus (CMV) multiple-organ disease caused by cytopathogenic tissue infection. The mechanism by which CMV-specific, naïve CD8 T cells become primed and clonally expand is of fundamental importance for our understanding of CMV immune control. For CD8 T-cell priming, two pathways have been identified: direct antigen presentation by infected professional antigen-presenting cells (pAPCs) and antigen cross-presentation by uninfected pAPCs that take up antigenic material derived from infected tissue cells. Studies in mouse models using murine CMV (mCMV) and precluding either pathway genetically or experimentally have shown that, in principle, both pathways can congruently generate the mouse MHC/H-2 class-I-determined epitope-specificity repertoire of the CD8 T-cell response. Recent studies, however, have shown that direct antigen presentation is the canonical pathway when both are accessible. This raised the question of why antigen cross-presentation is ineffective even under conditions of high virus replication thought to provide high amounts of antigenic material for feeding cross-presenting pAPCs. As delivery of antigenic material for cross-presentation is associated with programmed cell death, and as CMVs encode inhibitors of different cell death pathways, we pursued the idea that these inhibitors restrict antigen delivery and thus CD8 T-cell priming by cross-presentation. To test this hypothesis, we compared the CD8 T-cell responses to recombinant mCMVs lacking expression of the apoptosis-inhibiting protein M36 or the necroptosis-inhibiting protein M45 with responses to wild-type mCMV and revertant viruses expressing the respective cell death inhibitors. The data reveal that increased programmed cell death improves CD8 T-cell priming in mice capable of antigen cross-presentation but not in a mutant mouse strain unable to cross-present. These findings strongly support the conclusion that CMV cell death inhibitors restrict the priming of CD8 T cells by antigen cross-presentation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Virology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
- Leibniz Institute of Virology (LIV), Hamburg, Germany.
- Institute of Genetics, Technische Universität Braunschweig, Braunschweig, Germany.
- Virology and Innate Immunity Research Group, Helmholtz Centre for Infection Research, Braunschweig, Germany.
- Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
- Institute of Virology, Medical Faculty, University of Bonn, Bonn, Germany.
ORCID-Profile: Niels A W Lemmermann
Förderung
- Deutsche Forschungsgemeinschaft, Collaborative Research Center (CRC)
- Clinical Research Group
- Cluster of Excellence ImmunoSensation
- Deutsche Forschungsgemeinschaft
- Helmholtz-Gemeinschaft
Zitieren
APA
Ebert, S., Böhm, V., Büttner, J. K., Brune, W., Brinkmann, M. M., Holtappels, R., Reddehase, M. J., & Lemmermann, N. A. W. (2024). Cytomegalovirus inhibitors of programmed cell death restrict antigen cross-presentation in the priming of antiviral CD8 T cells. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012173
Vancouver
Ebert S, Böhm V, Büttner JK, Brune W, Brinkmann MM, Holtappels R, et al. Cytomegalovirus inhibitors of programmed cell death restrict antigen cross-presentation in the priming of antiviral CD8 T cells. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012173
BibTeX
@article{Ebert2024,
author = {Ebert, Stefan and Böhm, Verena and Büttner, Julia K and Brune, Wolfram and Brinkmann, Melanie M and Holtappels, Rafaela and Reddehase, Matthias J and Lemmermann, Niels A W},
title = {Cytomegalovirus inhibitors of programmed cell death restrict antigen cross-presentation in the priming of antiviral CD8 T cells},
journal = {PLOS Pathogens},
year = {2024},
doi = {10.1371/journal.ppat.1012173}
}
EUVIMED